Tizanidine Hydrochloride Tablet
Product Images NDC 61919-196

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 61919-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tizanidine Hydrochloride, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

196 (196 30)

The packaging label for Tizanidine 4 mg tablets, containing 30 tablets. The label includes the generic name Zanaflex and specifies that each tablet contains 4.576 mg tizanidine hydrochloride USP equivalent to 4 mg tizanidine base. The label shows a yellow background for the product name and strength. It is packaged and distributed by Direct Rx in Alpharetta, GA, and includes lot, proof, and discard after date details. Additional safety warnings and usage instructions are displayed on the side panels.*

FDA Label Image

Image Description (Module)

Chemical structure of tizanidine hydrochloride, showing the arrangement of atoms including chlorine and sulfur atoms within the bicyclic and heterocyclic rings characteristic of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.